A novel model demonstrating that human immune cells promote multiorgan SARS-CoV-2 dissemination and human T cells limit anti-viral innate immunity
Authors:
Preprint
Abstract
Despite extensive studies, many questions remain regarding the pathology and mechanisms behind Coronavirus disease 2019 (COVID-19), and particularly on post-acute sequelae of COVID-19 (PASC). Because existing mouse models cannot recapitulate human immune responses, we developed a human immune system (HIS) mouse model with physiologic expression of hACE2. After intranasal infection, persistent viral RNA was observed in multiple organs for 8 weeks, despite the generation of human SARS-CoV-2-specific T cell responses. Human immune cells increased viral infection in the lung and non-pulmonary tissues. COVID-19-related pathology was recapitulated in the lungs, with fibrosis peaking at 14 days post-infection. Immune activation was detected in the lungs, hearts, intestines and brains of acutely infected mice and persisted at 8 weeks in the heart and lungs. The presence of human T cells correlated with attenuated innate antiviral transcriptional signatures in the lung, where a persisting cytotoxic mature CD4+ T cell population with JAK-STAT activation was enriched in infected mice. Thus, human T cells mount an antigen-specific but ultimately dysfunctional response, while paradoxically suppressing the innate interferon response, permitting chronic interferon activation and long-term viral persistence, recapitulating several immunologic and histopathologic features associated with PASC. This model will uniquely facilitate understanding of virus-human immune dynamics and therapeutic approaches to PASC.Keywords
Funding Information
- National Institutes of Health (5T32AI106711-09)
- National Institutes of Health (3R01AI138547-03S1)
This publication has 119 references indexed in Scilit:
- T cell-driven sustained inflammation and immune dysregulation mimicking immunosenescence for up to three years post-COVID-19Immunity & Inflammation, 2025
- Angiotensin-Converting Enzyme-2 (ACE2) Downregulation During Coronavirus InfectionMolecular Biotechnology, 2024
- Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and managementSN Comprehensive Clinical Medicine, 2022
- Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimensAnalytical and Bioanalytical Chemistry, 2021
- Role of Toll‐like receptors in the pathogenesis of COVID‐19Journal of Medical Virology, 2021
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19Cell, 2020
- Coronaviruses and Immunosuppressed Patients: The Facts During the Third EpidemicLiver Transplantation, 2020
- Rapid thymectomy of NSG mice to analyze the role of native and grafted thymi in humanized miceEuropean Journal of Immunology, 2019
- The Applicability of Mouse Models to the Study of Human Disease2019
- Comprehensive Phenotyping of T Cells Using Flow CytometryCytometry Part A, 2019